Spectral Diagnostics Inc. West Nile Virus Test Reviewed.

M2 Presswire, December, 2006

M2 PRESSWIRE-13 December 2006-Pinnacle Digest: Spectral Diagnostics Inc. West Nile Virus Test Reviewed(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:13122006 Spectral Diagnostics Inc. (TSX: SDI) witnessed a phenomenal shift in its share value Tuesday. On Tuesday, shares of Spectral Diagnostics Inc.

increased an impressive 118 as 810,000 shares traded hands. PinnacleDigest believes the rapid rise in market value for this company, may be directly related to the FDA's approval of its West Nile Virus test. The Centers for Disease Control reported that WNV resulted in 135 known fatalities ...